CSI-UCSF 2017 , United States of America - Home


September 8 – 9, 2017
San Francisco, USA

CSI-UCSF 2017 , United States of America: Catheter Interventions in Congenital, Structural and Valvar Heart Disease - CSI-UCSF 2017 CSI-UCSF 2017 Catheter Interventions in Congenital, Structural and Valvar Heart Disease
CSI-UCSF 2017 , United States of America

CSI-UCSF
September 8 - 9, 2017
San Francisco, USA



Please keep me
updated
csi pfeil
subscribe now

CSI-UCSF 2017 Topics Program Overview Program Details Scientific Faculty Registration Abstracts & Cases Key Information Supporters Event Calendar
Fontsize bigger
  CSI-UCSF 2017 , United States of America: Catheter Interventions in Congenital, Structural and Valvar Heart Disease
CSI-UCSF 2017 , United States of America: Catheter Interventions in Congenital, Structural and Valvar Heart Disease

Board of Directors

Horst Sievert, MD

CardioVascular Center Frankfurt CVC
Frankfurt
Germany

Board of Directors: Horst Sievert, MD
More

Horst Sievert, MD

CardioVascular Center Frankfurt CVC
Frankfurt, Germany

Board of Directors: Horst Sievert, MD
Director and Founder of CVC Frankfurt

Specialist in Internal Medicine, Cardiology, Angiology, and Intensive Care

Medical degree from Johannes Gutenberg University Mainz and Johann Wolfgang Goethe University Frankfurt, Germany

Dr. Sievert has been the Principal Investigator of a number of clinical trials and has authored more than 130 manuscripts and 600 abstracts in peer reviewed journals, as well as 70 books and book contributions. He has also delivered more than 600 invited lectures around the world.
 
He has personally performed more than 16,000 PCIs and 6,000 peripheral angioplasties. However, his activity in the cath lab is focused on highly specialized non-coronary interventions for patients with congenital heart disease, carotid disease, or high risk of stroke, among other conditions. Dr Sievert was the first to close the left atrial appendage percutaneously. He has the largest experience worldwide in catheter closure of heart defects in adults and gets referrals from all over the world.

Neil Wilson, MD

School of Medicine, University of Colorado, Childrens Hospital Colorado
Denver
USA

Board of Directors: Neil Wilson, MD

Randall Lee, MD

University of California
San Francisco
USA

Board of Directors: Randall Lee, MD
More

Randall Lee, MD

University of California
San Francisco, USA

Board of Directors: Randall Lee, MD
Education
1984 UCLA School of Medicine 

Residencies
1988 Harbor-UCLA Medical Center, Internal Medicine
 
Fellowships
1991 Stanford University Medical Center, Cardiovascular Diseases 

Dr. Randall J. Lee graduated from UCLA Medical School in 1984 where he also obtained his doctorate in pharmacology. After completing an internal medicine residency at Harbor-UCLA Medical Center in Torrance, Calif., he completed a cardiology fellowship and postdoctoral fellowship in biochemistry and molecular biology at Stanford University, where he earned a Physician Scientist Award and the Upjohn Young Investigator Award in cardiology. Lee subspecialized in cardiac electrophysiology during his second fellowship at UCSF.
His research focuses on cellular and molecular aspects of cardiac arrhythmias and vascular regeneration. He is investigating the cellular and molecular derangements that occur during cardiac arrhythmias and myocardial infarctions. Lee uses genetic engineering techniques to investigate derangements during cardiac arrhythmias and myocardial infarctions and as possible therapeutic tools. Lee also is interested in cardiac development of the conduction system and the means to alter conduction, which then may be applied to diseased states.

Vaikom Mahadevan, MD

University of California
San Francisco
USA

Board of Directors: Vaikom Mahadevan, MD

Invited Faculty

Theodore P. Abraham, MD

UCSF
San Francisco
USA

Invited Faculty: Theodore P. Abraham, MD

Zahid Amin, MD

Children’s Hospital of Georgia Regents University
Augusta
USA

Invited Faculty: Zahid Amin, MD
More

Zahid Amin, MD

Children’s Hospital of Georgia Regents University
Augusta, USA

Invited Faculty: Zahid Amin, MD
PRESENT POSITION

Professor of Pediatrics
Chief, Division of Pediatric Cardiology, Children’s Hospital of Georgia, Georgia Regents University, Augusta, GA
FAAP, FSCAI, FACC, FAHA

ACADEMIC APPOINTMENTS
  • 2008 – today Professor of Pediatrics, Director of Cardiac Catheterization & Hybrid Suite, Rush University Medical Center
  • 2006 - 2008 Professor of Pediatrics, University of Nebraska Medical Center
  • 2000 - 2008 Associate Professor of Pediatrics, University of Nebraska Medical Center
  • 2004 - 2008 Associate Clinical Professor of Pediatrics, Creighton University School of Medicine
  • 2000 - 2004 Assistant Clinical Professor of Pediatrics, Creighton University School of Medicine
  • 1998 - 1999 Assistant Professor in Pediatric Cardiology, Medical College of Georgia
CERTIFICATIONS
  • Diplomate, American Board of Pediatrics, January 1996
  • Diplomate, Sub-board of Pediatric Cardiology, August 2002
CONSULTING POSITIONS (active)
  • 2000 – Present The Nebraska Medical Center, Omaha, Nebraska
  • 2000 – 2008 Children’s Hospital, Omaha, Nebraska
HONORS AND AWARDS
  • Session Chair. 4th World Congress of Pediatric Cardiology and Cardiac Surgery.  Buenos Aires, Argentina. 20 Sep 2005.
  • Elected to Honorary Membership in the Russian Scientific Society of Interventional Radiology and Endovascular Surgery. June 2005
  • Best Paper, Awarded by Midwest Pediatric Cardiology Society, 2000.
  • Fellow of the Year, Awarded by Midwest Pediatric Cardiology Society, 1997 – 1998.
  • Outstanding Fellow, Denton A. Cooley Cardiovascular Surgery Society, 1990 – 1992.





                                                                                                                     

Jason Anderson, MD

Mayo Clinic
Rochester
USA

Invited Faculty: Jason Anderson, MD
More

Jason Anderson, MD

Mayo Clinic
Rochester, USA

Invited Faculty: Jason Anderson, MD
Jason Anderson graduated from the University of Iowa Carver College Of Medicine in 2011. He went on to complete his education in Pediatrics and Pediatric Cardiology at Mayo Clinic where he has been appointed to the position of Assistant Professor of Pediatrics in the Mayo School of Graduate Medical Education since 2016. He is now undergoing additional training in pediatric and congenital interventional cardiology under the mentorship of Dr. Philip Moore at UCSF and will return to practice at Mayo Clinic upon completion. Specific interests include transcatheter valve implantation, device closure of septal defects, and intracardiac echocardiography.

Nitish Badhwar




Invited Faculty: Nitish Badhwar

Stefan Bertog, MD

CardioVascular Center Frankfurt CVC, Frankfurt, Germany
Minneapolis Medical Center, Minneapolis,
USA

Invited Faculty: Stefan Bertog, MD
More

Stefan Bertog, MD

CardioVascular Center Frankfurt CVC, Frankfurt, Germany
Minneapolis Medical Center, Minneapolis,, USA

Invited Faculty: Stefan Bertog, MD
Specialist in Cardiology, Angiology and Interventional Cardiology at CVC Frankfurt since February 2013

  • Since 2006 Assistant Professor, Department of Medicine, University of Minnesota, Minneapolis, Minnesota, USA
  • 2010 - Present Co-Director of Cardiac Catheterization Laboratory, Veterans Administration Hospital, Minneapolis, Minnesota, USA
  • 2006 - Present Cardiologist, Veterans Administration Hospital, Minneapolis, Minnesota, USA
  • 2003 - 2005 Chief Fellow Cardiology,, University of Minnesota, Minneapolis, Minnesota, USA
  • 2002 - 2006 Fellowship, Cardiology and Interventional Cardiology at University of Minnesota, Minneapolis, USA
  • 1999 - 2002 Residency, Internal Medicine at the Cleveland Clinic Hospital, Cleveland, Ohio, USA
  • 1997 - 1998 Junior Physician, Department of Cardiology at Municipal Hospital in Frankfurt Höchst, Germany
  • 1990 - 1997 Medical Degree at Johann Gutenberg University in Mainz, Germany







Todd Brinton, MD

Stanford University
Stanford
USA

Invited Faculty: Todd Brinton, MD
More

Todd Brinton, MD

Stanford University
Stanford, USA

Invited Faculty: Todd Brinton, MD
Todd Brinton is a Clinical Associate Professor of Medicine (Cardiology) and Consulting Associate Professor of Bioengineering at Stanford University. He is an attending interventional cardiologist at both Stanford University Medical Center and the Palo Alto VA Medical Center. He has served as the Innovation Fellowship Director for Stanford Biodesign since 2005 and also co-directs the Stanford graduate course series in Biodesign Innovation.

Dr. Brinton lectures on strategies for innovation and serves as a mentor to innovation fellows, graduate students, and executives. His academic research focuses on the process of innovation for development of novel medical technologies. He specifically focuses on the integration of research and development for new technologies with the clinical strategy and pre-clinical evaluation. He has served as a clinical investigator for a number to studies of interventional-based therapies for chronic ischemia heart disease and heart failure.

Dr. Brinton completed his medicine, cardiology, and interventional cardiology training at Stanford University. He holds an MD from the Chicago Medical School and a BS in Bioengineering from the University of California, San Diego. He is Co-Founder and Board Director for Shockwave Medical and BioParadox, Inc., which are both venture-backed medical device companies in the cardiovascular space. He also serves on the board of directors of Qool Therapeutics and Infogard Laboratories. In addition, he serves on the advisory board of a number of early-stage medical device companies, where he focuses on clinical development and strategy. Prior to medical school, he was the Clinical Research Director for Pulse Metric, Inc., a venture-backed medical device start-up company.

Ryan Brown




Invited Faculty: Ryan Brown

Maurice Buchbinder, MD

Foundation for Cardiovascular Medicine
San Diego
USA

Invited Faculty: Maurice Buchbinder, MD

John Carroll, MD

University of Colorado Hospital
Aurora
USA

Invited Faculty: John Carroll, MD
More

John Carroll, MD

University of Colorado Hospital
Aurora, USA

Invited Faculty: John Carroll, MD
Dr. Carroll received his AB (biology) cum laude from Princeton University in 1972 and his MD (Alpha Omega Alpha) from the University of Chicago in 1976.  He at Tufts New England Medical Center from 1976-1981 finishing as the Samuel Levine Cardiology Research Fellow of the American Heart Association. He then was a cardiology research fellow at Universittaetspital in Zurich, Switzerland. From 1982-1996 he was a member of the faculty at the University of Chicago Pritzker School of Medicine and directed the Hans Hecht Cardiac Catheterization Laboratory. He and his partner, Ted Feldman, started performing aortic and mitral valvuloplasties together starting in 1985. In 1996 he moved to the University of Colorado as Professor of Medicine, Director of Interventional Cardiology, and Co-Medical Director of the Cardiac and Vascular Center.  He has developed the interventional program at the University of Colorado with his partner, John Messenger.

He is currently a member of various national and international editorial and advisory boards, the STS-ACC Transcatheter Valve Therapy Registry Steering Committee, and the Steering Committee of the RESPECT trials.
 
Dr. Carroll is an interventional cardiologist with clinical and investigative interests related to structural/valvular heart disease interventions and the development of advanced cardiac 3D imaging for image guidance. He has collaborated with James Chen, PhD, for over 25 years. Dr. Carroll has co-edited with John G. Webb, MD of Vancouver the first textbook on “Structural Heart Disease Interventions”.

Andrea Colli, MD

University of Padua
Padua
Italy

Invited Faculty: Andrea Colli, MD
More

Andrea Colli, MD

University of Padua
Padua, Italy

Invited Faculty: Andrea Colli, MD
After finishing Medical School at University of Modena and Reggio Emilia, Italy  Dr. Colli’s medical career started with the residency in Cardiac Surgery at University of Parma (2001), Dr. Colli’s career continued in Spain at University of Barcelona with a 2 year fellowship. Dr. Colli’s career continued as Staff Surgeon at Hospital Universitari Germans Trias i Pujol. Dr. Colli Academic and surgical career continued in Padua, Italy as Assistant Professor of Cardiac Surgery (November 2011).

James Cox, MD




Invited Faculty: James Cox, MD

Francesca Nesta Delling, MD

University of California, San Francisco
San Francisco
USA

Invited Faculty: Francesca Nesta Delling, MD

Paolo Denti, MD

San Raffaele University Hospital
Milan
Italy

Invited Faculty: Paolo Denti, MD
More

Paolo Denti, MD

San Raffaele University Hospital
Milan, Italy

Invited Faculty: Paolo Denti, MD
Responsible of transcatheter therapy for mitral disease as Hybrid Cardiovascular Surgeon since 9/2013 in the Heart Surgery Dept at San Raffaele Hospital, Milan. Adjunct Professor for “Hybrid Cardiac Surgery” and for Master in Interventional Cardiology since 9/2014 at University Vita e Salute, Milan.
Hydrid training in surgical theatre (Prof. Alfieri) and Cath Lab (Prof. Colombo). ESC Fellow and EACTS Member.
Expert Mitraclip implanter (more 100 cases/year). Implanter of 1st Tiara (percutaneous mitral valve) in Italy (2nd Europe). 23/03/2016). 3rd Operator at FIM (First in man) implantation of the first percutaneous annuloplasty band (Cardioband) in 2013 in San Raffaele and Percutaneous Tricuspid valve repair (Tricinch) (2014). Expert on Minimally invasive mitral valve repair included Neochord Transapical implantation, TAVI  (TF, Tap, Tao) either valve in valve mitral and aortic and valve in ring procedures.
Author and co-author of more than 50 papers on peer reviewed journals and book chapters. Honoured of the podium in all renewed international congresses. Involved in sperimental animal surgery and in development of new cardiac devices.
Core interests in innovations, new percutaneous approach to structural heart disease (in particular mitral valve repair and aortic valve implantation), pre-clinical animal/bench study for development of new cardiac devices.

Tobias Deuse, MD

UCSF
,

Invited Faculty: Tobias Deuse, MD
Tobias Deuse, M.D. is a cardiac surgeon internationally renowned for his expertise in minimally-invasive mitral valve surgery. He earned an M.D. from University of Wuerzburg in 2000. Dr. Deuse thereafter received advanced training in cardiothoracic surgery at the University Hospital Munich-Grosshadern, the University Heart Center Hamburg-Eppendorf, and Stanford University. He achieved international acclaim for the development of innovative approaches for mitral valve surgery and demonstrated that high success rates can be achieved in endoscopic mitral valve repair even for complex valve pathologies. He is the Director for Minimally-invasive Cardiac Surgery at UCSF.

Shephal Doshi, MD

Saint John's Health Center, Pacific Heart Institute
Santa Monica, California
USA

Invited Faculty: Shephal Doshi, MD

Gan Dunington




Invited Faculty: Gan Dunington

Danny Dvir, MD

University of Washington
Seattle
USA

Invited Faculty: Danny Dvir, MD
More

Danny Dvir, MD

University of Washington
Seattle, USA

Invited Faculty: Danny Dvir, MD
Danny Dvir has large experience in structural heart interventions. He is the president of the board of the Institute of Valvular Research and is internationally recognized as an expert in evaluating and treating prosthetic heart valves, including valve-in-valve therapy. Dr. Dvir was trained in Internal Medicine and Cardiology in Israel. Subsequently, he had Cardiac Interventions fellowship training in in Washington DC and later on worked extensively and specialized in non-invasive strategies for the treatment of heart valves in the Center for Heart Valve Innovation in Vancouver, BC. Dr. Dvir is a faculty in the University of Washington.

Christopher Ellis, MD

Vanderbilt Heart and Vascular Institute
Nashville
USA

Invited Faculty: Christopher Ellis, MD

Marvin Eng, MD

Henry Ford Health System
Detroit
USA

Invited Faculty: Marvin Eng, MD
More

Marvin Eng, MD

Henry Ford Health System
Detroit, USA

Invited Faculty: Marvin Eng, MD
Marvin H. Eng MD graduate from Wayne State School of Medicine and completed his internal medicine and general cardiology training at the University of Colorado Health Sciences Center. Subsequently, Dr. Eng completed his interventional cardiology training at the Scripps Clinic in La Jolla, California.  His first faculty appointment was at the University of Texas Health Sciences Center-San Antonio where he started the TAVR program at the University.  Since arriving back in Detroit in 2015, Dr. Eng currently serves as the Structural Heart Disease (SHD) Fellowship and the SHD research director.  His focus includes imaging, large bore access, TAVR and mitral interventions.   

Ted Feldman, MD

Evanston Hospital
Evanston
USA

Invited Faculty: Ted Feldman, MD
More

Ted Feldman, MD

Evanston Hospital
Evanston, USA

Invited Faculty: Ted Feldman, MD
Dr. Feldman received his undergraduate and medical training at Indiana University, completing residency training as Chief Resident at Rush-Presbyterian-St. Luke's Medical Center, Chicago, Illinois. After finishing his Cardiology Fellowship at the University of Chicago, he remained there as Professor of Medicine and Director of the Cardiac Catheterization Laboratory.

He currently practices at Evanston Hospital, where he is Director of the Cardiac Catheterization Laboratory, holds the Walgreen Chair in Interventional Cardiology, and is Professor of Clinical Medicine at University of Chicago Medical School.

He has authored over 500 manuscripts, chapters, abstracts, and editorials and edited or co-edited several books. He is a Percutaneous Coronary Intervention Guideline co-author and has served on the American Board of Internal Medicine Interventional Cardiology test writing committee. Chicago Magazine has repeatedly named him among Chicago’s Top Doctors.

Dr. Feldman is a past-President of the Society of Cardiovascular Angiography & Interventions, and chaired the Annual Scientific Sessions of the Society, as well as the American College of Cardiology Interventional Sessions.

He is an active interventional practitioner and performs hundreds of catheter procedures every year. He has been the national principal investigator of the EVEREST MitraClip trial and the REPRISE III TAVR trial, and participates in numerous clinical investigations, with major research interests that include non-surgical, percutaneous repair of the mitral valve, catheter based aortic valve replacement, shunt closure for congenital heart disease, left atrial appendage closure, and development of new catheter devices.

Paul Friedman




Invited Faculty: Paul Friedman

Sameer Gafoor, MD

Swedish Heart and Vascular Institute
Seattle
USA

Invited Faculty: Sameer  Gafoor, MD
More

Sameer Gafoor, MD

Swedish Heart and Vascular Institute
Seattle, USA

Invited Faculty: Sameer  Gafoor, MD
Attending Physician

Dr. Sameer Gafoor is an attending physician at the CardioVascular Center (CVC) Frankfurt headed by Horst Sievert, MD. He obtained his medical degree from Northwestern University in the United States, followed by Internal Medicine Residency at University of michigan. His cardiology training started with Cardiovascular Disease Fellowship at Washington Hospital Center/Georgetown University and continued with Interventional Cardiology Fellowship at Emory University.

Following this training, he went on to complete an Advanced Fellowship in Neurovascular, Coronary, Structural Heart, and Peripheral Vascular Training at the CVC Frankfurt. He specializes in interventions and imaging for structural heart and peripheral vascular disease, as well as development and incorporation of new devices, technologies, and techniques for these and other indications.

Achille Gaspardone, MD


Rome
Italy

Invited Faculty: Achille Gaspardone, MD

Edward P. Gerstenfeld, MD

UCSF
San Francisco
USA

Invited Faculty: Edward P. Gerstenfeld, MD

Eberhard Grube, MD

University Hospital Bonn
Bonn
Germany

Invited Faculty: Eberhard Grube, MD
More

Eberhard Grube, MD

University Hospital Bonn
Bonn, Germany

Invited Faculty: Eberhard Grube, MD
Prof. Grube is Professor of Medicine, Head, Center of Innovative Interventions in Cardiology (CIIC)University Hospital Bonn,Germany and Consulting Professor, Division of Cardiovascular Medicine, at Stanford University School of Medicine.
He received his first degree in Medicine at the Rheinische Friedrich-Wilhelm-University in Bonn. His cardiology training was completed at University of Wisconsin, Medical School and University of Bonn, Medical School.
He received his Board Certification in Internal Medicine, in Cardiology and in Angiology from the North Rhine Chamber of Medical Doctors and his post-doctoral lecturing qualification “Internal Medicine“ from the Rheinische Friedrich-Wilhelm-University in Bonn.
He is a fellow of the American College of Cardiology, the American College of Angiology and the Society for Cardiac Angiography & Interventions.

His research interest include drug eluting stents, distal protection devices, debulking devices, restenosis and in-stent restenosis.

Julius Guccione

UCSF School of Medicine
San Francisco
USA

Invited Faculty: Julius Guccione

Ian Harris

University of California, San Francisco
San Francisco
USA

Invited Faculty: Ian Harris

David Holmes, MD

Mayo Clinic
Rochester
USA

Invited Faculty: David Holmes, MD
More

David Holmes, MD

Mayo Clinic
Rochester, USA

Invited Faculty: David Holmes, MD
Dr. Holmes is currently a Professor of Medicine at the Mayo Clinic College of Medicine and a consultant in the Department of Cardiovascular Medicine at Mayo Clinic in Rochester, Minnesota. Dr. Holmes has also been named the Edward W. and Betty Knight Scripps Professor in Cardiovascular Medicine in Honor of Dr. George M. Gura, Jr.  He was awarded an Honorary Fellowship of the Royal College of Physicians in Ireland in November 2011.  He has received the Distinguished Scientist Award (Clinical Domain) from the American College of Cardiology and the Research Career Achievement Award from the Mayo Graduate School of Medicine.  He is a Past President of the American College of Cardiology (ACC) as well as the Society for Cardiac Angiography and Interventions (SCAI).  He has lectured widely both nationally and internationally.  He has received the Herrick Award from the American Heart Association.     

His special areas of interest include acute coronary syndromes, interventional cardiology, restenosis, vascular biology, and risk outcomes analysis.  In addition, he has been involved in the development of new catheter designs for stroke prevention using left atrial appendage occlusion technology.  He has been involved with the introduction and dispersion of transcatheter aortic valve replacement in the United States working with both ACC and the Society for Thoracic Surgery (STS).  As part of that, he has been involved with regulatory agencies including FDA and CMS.  This collaboration has led to the development of a working group on Early Feasibility Studies (EFS).  Finally, he is involved in the development of continued application of percutaneous coronary intervention technology to noncoronary vascular beds.

Dr. Holmes received his medical degree at Medical College of Wisconsin in Milwaukee and completed his internship at Virginia Mason Hospital in Seattle.  He also served in the United States Navy at the National Naval Medical Center in Bethesda.

Michael Hope




Invited Faculty: Michael Hope

Jonathan Hsu, MD

University of California, San Diego
La Jolla
USA

Invited Faculty: Jonathan Hsu, MD
More

Jonathan Hsu, MD

University of California, San Diego
La Jolla, USA

Invited Faculty: Jonathan Hsu, MD
Dr. Jonathan Hsu is an Assistant Clinical Professor of Medicine at UCSD School of Medicine, Division of Cardiology.  His primary clinical interest is in cardiac electrophysiology, and he specializes in both the medical and procedural care of patients with all types of heart rhythm disturbances.  
Dr. Hsu is also a clinical research investigator with formal advanced training (Master’s Degree) in clinical research methods and biostatistics.  His research focuses on the epidemiology and clinical outcomes in patients with all types of cardiac arrhythmias and devices, including reducing the risk of stroke in atrial fibrillation patients with oral anticoagulants and reducing complications in implantable-cardioverter defibrillator recipients.  Dr. Hsu is also actively involved in formal didactic teaching at the UCSD School of Medicine, and is dedicated to the education mission of UCSD through instruction of medical students, residents, and fellows.
Dr. Hsu is specially trained in catheter ablation to treat arrhythmias such as supraventricular tachycardia (including atrial fibrillation) and ventricular tachycardia in addition to implantation and management of cardiac rhythm devices including pacemakers, implantable-cardioverter defibrillators, and cardiac resynchronization therapy (biventricular) devices.  He is specially trained in performing left atrial appendage occlusion and left atrial appendage ligation for stroke risk reduction in patients with atrial fibrillation.
Dr. Hsu has a special clinical interest in quality of cardiovascular care improvement and outcomes research.  He has specific expertise in Registry and large database analyses to improve the medical and procedural care of patients with arrhythmias.
Dr. Hsu completed fellowship training in general cardiology and received additional advanced sub-specialty training in cardiac electrophysiology at the University of California, San Francisco (UCSF), where he also completed his Master’s Degree in Clinical Research (MAS).  He completed both his internship and residency at Massachusetts General Hospital.  He earned his undergraduate and medical degree at Northwestern University.

Hasan Jilaihawi, MD

NYU Langone Medical Center
New York
USA

Invited Faculty: Hasan Jilaihawi, MD
More

Hasan Jilaihawi, MD

NYU Langone Medical Center
New York, USA

Invited Faculty: Hasan Jilaihawi, MD
Hasan Jilaihawi, MD, is an Interventional Cardiologist,
and Associate Professor of Medicine and Cardiothoracic Surgery at NYU Langone Medical Center. He also directs the NYU Imaging Corelab and is Co-Director of Transcatheter Valve Therapies. He is heavily involved in all aspects of clinical cardiology, with a special interest in innovative methods of imaging the heart, complex percutaneous coronary intervention and device and patient selection for transcatheter aortic valve replacement (TAVR) and other heart valve therapies. In 2007, he was one of the two cardiologists who performed the first TAVR procedure in the United Kingdom.

Samir Kapadia, MD

Cleveland Clinic
Cleveland
USA

Invited Faculty: Samir Kapadia, MD
More

Samir Kapadia, MD

Cleveland Clinic
Cleveland, USA

Invited Faculty: Samir Kapadia, MD
Samir Kapadia, MD, is the Section Head of Invasive and Interventional Cardiology, the Director of the Sones Cardiac Catheterization Laboratories, and Director of the Interventional Cardiology Fellowship Program in the Robert and Suzanne Tomsich Department of Cardiovascular Medicine, Sydell and Arnold Miller Family Heart & Vascular Institute at Cleveland Clinic. He is a Professor of Medicine at the Cleveland Clinic Lerner College of Medicine of Case Western Reserve University. Dr. Kapadia is board-certified in internal medicine, cardiology, and interventional cardiology.
Specialty/Clinical interests: Percutaneous treatment for valve disease, transcatheter aortic valve replacement (TAVR), Mitraclip, complex coronary interventions, atrial septal defect (ASD) and patent foramen ovale (PFO) closure, carotid interventions, peripheral interventions

Number of Procedures Performed: Dr. Kapadia has performed 1,000 TAVR procedures and thousands of other cardiovascular procedures throughout his career.

Success Rates: Cleveland Clinic has been ranked the #1 hospital for cardiology and heart surgery by U.S. News & World Report since 1994. Success rates for specific procedures are available at: http://my.clevelandclinic.org/heart/about-heart-vascular-institute/treatment-outcomes.aspx

Education and Training: Dr. Kapadia received his medical degree with honors from Smt. NHL Municipal Medical College in Gujarat, India. He completed his internship and residency in internal medicine at Baylor College of Medicine, Houston, where he was named Outstanding Resident. Dr. Kapadia completed fellowships in cardiology and interventional cardiology at Cleveland Clinic, Cleveland, and was named Chief Interventional Fellow. Dr. Kapadia was appointed to Cleveland Clinic in 2003 as a Staff Interventional Cardiologist.
Prior to his appointment to Cleveland Clinic, Dr. Kapadia had an academic appointment to the Department of Medicine at the University of Washington, Seattle, and was an Interventional Cardiologist at the VA Puget Sound Health Care System, Seattle.
Research, Publications and Speaking: Dr. Kapadia has published more than 300 articles and abstracts in professional scientific journals.

About Dr. Kapadia: “I love to get to know the patients and families well so that I can provide appropriate care and meet their expectations. Procedural expertise is necessary for the best outcomes but not enough; compassionate clinical care is an essential element that we should not ignore.”

Leisure time activities: In his leisure time, Dr. Kapadia enjoys spending time with his family, astronomy, physics, and math.

Saibal Kar, MD

Cedars Sinai Medical Center
Los Angeles
USA

Invited Faculty: Saibal Kar, MD

Susheel Kodali, MD

Columbia University Medical Center
New York City
USA

Invited Faculty: Susheel Kodali, MD

Raghavannair Suresh Kumar, MD

National Heart Centre, Royal Hospital
Muscat
Oman

Invited Faculty: Raghavannair Suresh Kumar, MD
More

Raghavannair Suresh Kumar, MD

National Heart Centre, Royal Hospital
Muscat, Oman

Invited Faculty: Raghavannair Suresh Kumar, MD
●    Post graduate teacher in cardiology in Medical Colleges of Kerala. 1983 – 1991
●    Consultant at  the first comprehensive paediatric cardiac service in UAE at the Mafraq Hospital, Abu Dhabi, 1991 – 2004
●    Head of Paediatric Cardiology  at The Madras Medical Mission, Chennai and Frontier Lifeline, Chennai,India. 2004 – 2014
●    Course Director  at Advanced Cardiovascular Therapeutics, The Madras Medical Mission, Chennai. 2006 – 2012 .
●    Invited Speaker ,UCSF Cardiology Grand Rounds,April 13.2016
●    Author of over 30 publications and several text book chapters.
●    E-teacher for paediatric cardiology residents worldwide

Purshotam Lal, MD

Metro Group of Hospitals
Noida
India

Invited Faculty: Purshotam Lal, MD
More

Purshotam Lal, MD

Metro Group of Hospitals
Noida, India

Invited Faculty: Purshotam Lal, MD
 
DR.  PURSHOTAM   LAL
 
Dr. Purshottam Lal has been working as Director Interventional Cardiology and Chairman Metro Group of Hospitals. Trained in UK, Germany and USA, certified by American Speciality Board, Dr. P. Lal has been fellow of American College of Cardiology and fellow of Royal College of Physicians (Canada),
Fellow of Society of Cardiac Angiography and Interventions in USA. He has the unique distinction of introducing the largest number of procedures in the field of Interventional cardiology for the first time in the country such as slow rotational angioplasty, atherectomy, stenting, rotablator, heart hole closure  etc. and has been listed in Limca Book of World Records several times. He has developed his own technique of partial artificial heart and mitral valvoplasty without cath lab.
He has performed the first case of non-surgical closure of heart hole (ASD) with monodisc device and first case of non-surgical aortic valve replacement with core valve, both being first time in the world.  He has developed 12 hospitals with a mission ‘No patient should ever be returned for want of money’. He has been named as ‘Creator of Affordable Healthcare’ by ‘Express Healthcare’.
He was awareded by Dr. V.V.Shah Oration by Cardiological Society of India in 1992 and was selected for the award of Padma Shree in 1993. He was honoured with Distinguished Achievement Award of Highest Order by the National Forum of Indian Medical Association (2006-07) for performing the largest number of angioplasties/stenting as a single operator in the country. He has been awarded Padma Bhushan in 2003, Dr. B.C. Roy National Award in 2004 and Padma Vibhushan in 2009.
He has been Member, Central Council of Health and Family Welfare, Member of Expert Committee for medical devices, Ministry of Health, Govt. of India, Member of Delhi Medical Council, Member of Board of Governors, Medical Council of India and Member, Standing Committee ESI Corporation – Ministry of Labour & Employment, Govt. of India.




Raj Makkar, MD

Cedars-Sinai Medical Center
Los Angeles
USA

Invited Faculty: Raj Makkar, MD

Jeffrey Meadows, MD

UCSF Benioff Children’s Hospital
San Francisco
USA

Invited Faculty: Jeffrey Meadows, MD
More

Jeffrey Meadows, MD

UCSF Benioff Children’s Hospital
San Francisco, USA

Invited Faculty: Jeffrey Meadows, MD
Dr. Meadows is a pediatric cardiologist who specializes in interventional cardiac catheterization procedures in infants, children and adults with complex congenital and acquired heart disease. Dr. Meadows is Director of the Pediatric & Congenital Cardiac Catheterization Laboratory at the UCSF Benioff Children’s Hospital where he also serves as Director of the Pediatric Cardiopulmonary Exercise Testing Program.
 Dr. Meadows is an associate professor in the UCSF Division of Pediatric Cardiology. He earned a medical degree at Johns Hopkins University and completed an internship and residency in pediatric internal medicine and fellowships in pediatric cardiology and pediatric interventional cardiology at Children's Hospital in Boston. Dr. Meadows as also completed advanced training in biostatistics and clinical study design through the UCSF Department of Epidemiology and Biostatistics.

Roxana Mehran




Invited Faculty: Roxana Mehran

Suneet Mittal, MD

Valley Hospital
New York
USA

Invited Faculty: Suneet Mittal, MD
More

Suneet Mittal, MD

Valley Hospital
New York, USA

Invited Faculty: Suneet Mittal, MD
Dr. Mittal earned his BA and MD degrees from Boston University as part of a combined 6-year BA-MD program. He did an internship and residency in Internal Medicine as well as a fellowship in Cardiovascular Diseases at the Hospital of the University of Pennsylvania in Philadelphia, Pennsylvania. He then completed a fellowship in Clinical Cardiac Electrophysiology at the New York Presbyterian Hospital-Weill Cornell Medical Center. Dr. Mittal is board certified in Cardiovascular Disease and Clinical Cardiac Electrophysiology.

He is currently the Director of the Electrophysiology Laboratory and Associate Chief of Cardiology at The Valley Hospital in Ridgewood, New Jersey.

Dr. Mittal’s active research interests include the evaluation and management of patients with atrial fibrillation, the role of the left atrial appendage in patients with persistent atrial fibrillation, the evaluation and management of patients with unexplained syncope, the role of implantable monitors in patients with known or suspected arrhythmias, and overcoming barriers to remote patient monitoring.

He serves as the Heart Rhythm Society’s Co-Ambassador to India. He is currently an Associate Editor for the Heart Rhythm Case Reports Journal and an Editorial Board member of Heart Rhythm and the Journal of Interventional Cardiovascular Electrophysiology.

Philip Moore




Invited Faculty: Philip Moore

Gareth Morgan, MD

University of Colorado
Denver
USA

Invited Faculty: Gareth Morgan, MD
More

Gareth Morgan, MD

University of Colorado
Denver, USA

Invited Faculty: Gareth Morgan, MD
Gareth Morgan was appointed as a consultant congenital interventional cardiologist at Evelina Children’s Hospital and Guys and St Thomas’ hospital in London in June 2013.

Gareth’s subspecialty fellowship in interventional congenital cardiology was carried out with Dr Lee Benson at the Hospital for Sick Children, Toronto, Ontario 2008-2010.

He was first appointed consultant paediatric and adult congenital cardiologist at University Hospitals Bristol in 2010 and has been an honorary senior lecturer at the University of Bristol since 2011.

Gareth's undergraduate and early postgraduate training was at The Queens University of Belfast and the Royal Belfast Hospital for Sick Children.

Here he also completed his MPhil research thesis in paediatric cardiology before SpR training in paediatric and adult congenital cardiology at University Hospitals Bristol.

Joshua Moss

UCSF
San Francisco
USA

Invited Faculty: Joshua Moss
More

Joshua Moss

UCSF
San Francisco, USA

Invited Faculty: Joshua Moss
As a clinical cardiac electrophysiologist, I have expertise in catheter ablation techniques for complex arrhythmias, including ventricular tachycardia, supraventricular tachycardia, atrial fibrillation, and atrial flutter.  I am also skilled in surgical implantation of pacemakers, defibrillators, and biventricular devices.  I currently lead or participate in multiple clinical studies on existing and evolving techniques for treating patients with arrhythmias and congestive heart failure, including those with a ventricular assist device (VAD). Trained as an engineer prior to beginning my medical career, I also maintain an active research interest in novel device design for advanced cardiac rhythm management

Mubashir Mumtaz, MD

Pinnacle Health System
Harrisburg
USA

Invited Faculty: Mubashir Mumtaz, MD
More

Mubashir Mumtaz, MD

Pinnacle Health System
Harrisburg, USA

Invited Faculty: Mubashir Mumtaz, MD
Dr. Mumtaz has practiced in the Central Pennsylvania area since 2002.  He currently serves as the Chief of Cardiovascular & Thoracic Surgery at Pinnacle Health System since June of 2010 and is also the Surgical Director of the Pinnacle Health Structural Heart and Valve Clinic.  Under his direction, the Pinnacle Health Program has achieved three star ratings in all three categories (CAB only, AVR only, CAB/AVR only) and has maintained three star rating for CAB only for 7 consecutive rating periods.

Dr. Mumtaz completed his surgery residency at the University of Connecticut and Cardiothoracic fellowship at Penn State Milton S. Hershey Medical center.  He received advanced training at the Cleveland Clinic.

He is Board Certified by the American Board of Surgery and the American Board of Thoracic Surgery.

Specialties include mininally invasive surgery for valvular disease including transcatheter, robotic and right chest approaches; Total Thoracoscopic MAZE for atrial fibrillation; Coronary and Aortic Surgeries.

Allan Nugent

Children’s Health Dallas
Dallas
USA

Invited Faculty: Allan Nugent
More

Allan Nugent

Children’s Health Dallas
Dallas, USA

Invited Faculty: Allan Nugent
Dr Nugent trained in pediatrics and pediatric cardiology at the Royal Children’s Hospital in Melbourne Australia and completed fellowship in pediatric cardiology at Boston Children’s Hospital. He is currently the Director of Catheterization at Children’s Health Dallas and an Associate Professor Department of Pediatrics at UT Southwestern Medical Center. At UTSW he has been the lead investigator in testing biodegradable stents for congenital heart disease applications.

Eustaquio Maria Onorato , MD

Humanitas Gavazzeni Clinic
Bergamo
Italy

Invited Faculty: Eustaquio Maria  Onorato , MD
More

Eustaquio Maria Onorato , MD

Humanitas Gavazzeni Clinic
Bergamo, Italy

Invited Faculty: Eustaquio Maria  Onorato , MD
•    Medical Degree with honours
University of Milan, Milan School of Medicine, Italy (1977)
University of Zulia, Maracaibo School of Medicine, Venezuela (1980)

•    First Class Degree Certification, Cardiology
Post Graduate Course in Cardiology, University School of Medicine, Caracas, Venezuela (1984)

•    Degree Certification, Paediatric Cardiology
Post Graduate Course in Pediatric Cardiology, University School of Medicine, Caracas, Venezuela (1986)

•    Teaching Assistant Professor
Institute of Cardiology, University Hospital of Caracas, Venezuela (1985-1989)

•    Degree Certification, Radiology
Post Graduate Course in Radiology, University School of Medicine, Siena, Italy (1994).

•    Co-Director of the Cardiovascular Catheterization Laboratory
Centro "E. Malan", San Donato Hospital, University of Milan, Italy (1989-1997)

•    Director of Cardiology Department and Cardiac Catheterization Laboratory
Clinica San Rocco di Franciacorta, Ome, (Brescia), Italy (1997-2002)

•    Director of Cardiology Division I and Cardiac Catheterization Laboratory
Humanitas Gavazzeni Clinic, Bergamo, Italy (2002-2006)

•    Director of Cardiology Department and Cardiac Catheterization Laboratory
Ospedale Sant’Orsola Fatebenefratelli, Brescia, Italy (2006-2009)

•    Teaching Professor, Interventional Cardiology
  Policlinico Universitario Tor Vergata, University School of Medicine, Rome (2010 - 2011)

•    Current position:  Consultant , Interventional Cardiology, Congenital and Structural Heart Diseases
Cardiovascular Department, Humanitas Gavazzeni Clinic, Bergamo
Senior Consultant, Centro Cardiologico Monzino, University School of Medicine, Milan, Italy



•    Scientific Consultant, Proctor and Trainer, Congenital and Structural Interventional Cardiology;
•    Scientific Consultant, Proctor and Trainer, Intracardiac Ultrasound for catheter-based interventional procedures
Centro Cardiologico Monzino, University School of Medicine, Milan, Italy
    Clinica Montevergine, Mercogliano, Italy
    S.Anna Hospital, Catanzaro, Italy
    Presidio Ospedaliero San Giovanni di Dio, Agrigento
    Presidio Ospedaliero “S.Elia”, Caltanissetta
    Bakulev Scientific Center for Cardiovascular Surgery, Moscow Medical Academy, Russian Federation
    Republican Cardiology Center – Ufa, Republic of Bashkiria, Russian Federation
    Cardiology Institute, Kazan, Republic of Tatarstad, Russian Federation
    Cardiology Dept, Santariskiu Klinikos, University School of Medicine, Vilnius, Lithuania
    Centru Cardiovascular, Spitalul Monza – Bucarest, Romania
    Hungarian Institute of Cardiology – Pediatric Cardiac Centre – Budapest, Hungry
    Instituto de Cardiologia, Hospital Universitario de Caracas, University School of Medicine – Caracas, Venezuela
    Instituto Cardiovascular de Buenos Aires, Argentina
    Servicio de Cardiologia – Hemodinamia, Hospital de Los Valles – Quito, Ecuador
    Om El Kora Cardiac Center, University Hospital, Tanta, Egypt
    Pediatric Cardiology, Cairo University Children Hospital, Egypt
    Centre Hospitalier Universitaire (CHU) “Charles Nicole, Rouen, France
    Centre Hospitalier Universitaire (CHU) “Arnaud de Villenueve“, Montpellier, France
    Centre Hospitalier Régional Universitaire de Lille (CHRU), France
    American Heart Institute, Nicosia, Cyprus  



Scientific Society Memberships
National
•    Società Italiana di Cardiologia Pediatrica (SICP)
•    Gruppo Italiano di Studi Emodinamici e Cardiologia Interventistica (G.I.S.E.)
•    Associazione Medici Cardiologi Ospedalieri (A.N.M.C.O.): Fellow
•    Società Italiana di Radiologia Medica (SIRM)
International
•    Sociedad Venezolana de Cardiologia
•    Sociedad Latina de Cardiologia Pediatrica
•    The Society for Cardiac Angiography and Interventions (SCAI): Fellow
•    European Society of Cardiology (ESC): Fellow
•    Russian Scientific Society of Interventional Radiology & Endovascular Surgery: Honorary Membership
•    Sociedad Venezolana de Cardiologia Intervencionista : Honorary Membership


Field of Interest and Clinical Research
Interventional Percutaneous Procedures in Congenital and Structural Heart Diseases in Childrens and Adults:
-    Interatrial communications: atrial septal defect and patent foramen ovale (PFO) closure
-    Ventricular sepal defect closure (perimembranous, muscular)
-    Post-infarction ventricular septal rupture closure  
-    Patent ductus arteriosus closure
-    Pulmonary arteriovenous malformations and coronary artery fistulas closure
-    Paravalvular Leak percutaneous closure
-    Left Atrial Appendage Closure  
-    Balloon Valvuloplasty for pulmonary valve and aortic valve stenosis
-    Other complex congenital heart defects

Augusto Pichard, MD

MedStar Washington Hospital Center
Washington, DC
USA

Invited Faculty: Augusto Pichard, MD
More

Augusto Pichard, MD

MedStar Washington Hospital Center
Washington, DC, USA

Invited Faculty: Augusto Pichard, MD
Augusto D. Pichard, MD, is Director Emeritus of the Cardiac Catheterization Laboratories and former Director of Innovation and Structural Heart Disease at Medstar Washington Hospital Center in Washington, DC.
Dr Pichard built 11 Cardiac Cath Labs at the MWHC, known for high quality, efficiency and scientific achievements; with the highest procedural volume and scientific output in the world during many years. He also built 3 Hybrid OR/Cath Labs for the performance of complex structural heart disease procedures, and created a sophisticated Structural Heart Team. Additionally, he is  a committed academician and is a Professor of Medicine (Cardiology) at Georgetown University. He is a dedicated teacher and has trained many physicians in the Cath Labs who are now leaders in the specialty around the world; he received the J. Lindsay Award for Best Teacher.
Dr. Pichard is active in clinical research. His research expertise is in Invasive Cardiology, including coronary angioplasty, intracoronary imaging and physiology, percutaneous valve repair and replacement. In addition, he trains American and international cardiologists in the percutaneous treatment of coronary and structural heart disease. He has been the PI for numerous trials.
Dr Pichard travels extensively lecturing about his specialty, and is a recognized international leader in Interventional Cardiology.
Dr. Pichard is Board Certified in Internal Medicine, Cardiovascular Disease, and Interventional Cardiology. He has written more than 700 manuscripts for peer-reviewed journals on numerous topics in Cardiology. He also is active in national and international educational activities related to his specialty. Dr. Pichard serves on several editorial boards and is a Fellow of numerous professional organizations, both in the United States and abroad. He is a founder Fellow of the Society for Cardiac Catheterization and Interventions (SCAI) and was a trustee of that Society.
Dr Pichard graduated with highest honors from the Catholic University of Chile. He completed Cardiology Fellowship at the Cleveland Clinic (1971-3) and stayed on Staff at the Cleveland Clinic until 1975. He was Director of the Cath Labs at Mount Sinai Hospital New York 1975-81; and started Coronary Angioplasty at that Institution. He took a Sabbatical at the Catholic University in Chile 1982, where he initiated Angioplasty and a Clinical Research Program. He came to Washington in 1983 as Director of the Cath Labs at the Washington Hospital Center and Professor of Medicine of the George Washington University.
Dr Pichard had been very active in numerous Boards at the Medstar Washington Hospital Center, including the Hospital Board of Directors, Foundation Board, Medical and Dental Staff Board, WHC Research Board, Washington Cardiology Center Board, and Vice Chair of the Heart and Vascular Institute.

Atif Qasim




Invited Faculty: Atif Qasim

John F. Rhodes, Jr., MD

Miami Children’s Health System
Miami
USA

Invited Faculty: John F. Rhodes, Jr., MD
More

John F. Rhodes, Jr., MD

Miami Children’s Health System
Miami, USA

Invited Faculty: John F. Rhodes, Jr., MD
Dr. Rhodes is “The Heart Program”, Medical Director for Pediatric Cardiology and the Adult Congenital Heart Program at Miami Children’s Hospital.  Prior to joining Miami Children’s, Dr. Rhodes served as chief for the Duke Clinical Heart Program and Duke Children’s Heart Center in Durham, North Carolina.  He was also co-director of the Duke Adult Congenital Heart Program.  
Dr. Rhodes received his medical degree from The Brody School of Medicine in Greenville, North Carolina and completed his fellowship in cardiology at The Mount Sinai Medical Center in New York.  He pursued additional training in interventional catheterization for children and adults at The Cleveland Clinic Foundation in Cleveland.  
Dr. Rhodes’ clinical interests involve diagnostic and interventional catheterization procedures for children and adults with complex congenital heart disease.  He has helped pioneer several techniques, including transcatheter atrial septal closure with the Gore Helex Septal Occluder, intracardiac echocardiographic imaging to guide catheter interventions, cutting balloon angioplasty of stenotic branch pulmonary arteries, and pulmonary vein stenosis following radiofrequency ablation of atrial fibrillation.  He is currently the National Principal Investigator for the REDUCE trial for the management of patent foramen ovale in the setting of cryptogenic stroke and is an investigator for trials including the new Gore Septal Occluder device, Edwards Lifesciences pulmonary stent valve, MELODY pulmonary stent valve, and covered stent angioplasty for coarctation of the aorta.

Carlos E. Ruiz, MD

Hackensack University Medical Center and The Joseph M. Sanzari Children's Hospital
Hackensack
USA

Invited Faculty: Carlos E. Ruiz, MD

Tamara Sandodze




Invited Faculty: Tamara Sandodze

Jacqueline Saw, MD

Vancouver General Hospital
Vancouver
Canada

Invited Faculty: Jacqueline Saw, MD
More

Jacqueline Saw, MD

Vancouver General Hospital
Vancouver, Canada

Invited Faculty: Jacqueline Saw, MD
Dr. Jacqueline Saw is an Interventional Cardiologist at Vancouver General Hospital and St Paul’s Hospital, Clinical Associate Professor of Medicine at UBC, and Program Director of the VGH Interventional Cardiology Fellowship Program. She served as Head of VGH Cardiology Clinical Trials Research. She is an active physician proctor for LAA closure with WATCHMAN and ACP/Amulet devices.

Dr. Saw is a pioneer in research and management of spontaneous coronary artery dissection (SCAD) and is the PI of the CIHR-funded multi-center prospective Canadian SCAD Study. Other research interests include LAA closure, coronary fibromuscular dysplasia, antiplatelet therapy, carotid artery stenting, peripheral arterial disease and intervention. She is also PI of PRYME, NACAD, SAFER-SCAD, Canadian WATCHMAN Registry, TAP-CABG, and ELAPSE studies. She has co-authored over 130 peer-reviewed publications, and is the editor of three textbooks on LAA closure and carotid artery stenting.

Nelson Schiller, MD

UCSF
San Francisco
USA

Invited Faculty: Nelson Schiller, MD

Van Selby

UCSF
San Francisco
USA

Invited Faculty: Van Selby

Warren Sherman, MD

LoneStar Heart, Inc.
New York
USA

Invited Faculty: Warren Sherman, MD

Kolja Sievert

CardioVascular Center Frankfurt CVC
Frankfurt
Germany

Invited Faculty: Kolja Sievert

Jagmeet Singh




Invited Faculty: Jagmeet Singh

Paul Teirstein




Invited Faculty: Paul Teirstein

David Tschopp, MD

Austin Heart
Austin
USA

Invited Faculty: David Tschopp, MD

Mintu P. Turakhia, MD

Stanford University School of Medicine
Stanford
USA

Invited Faculty: Mintu P. Turakhia, MD
More

Mintu P. Turakhia, MD

Stanford University School of Medicine
Stanford, USA

Invited Faculty: Mintu P. Turakhia, MD
Associate Professor
Executive Director, Center for Digital Health
Stanford University School of Medicine

Chief of Cardiac Electrophysiology, VA Palo Alto Health Care System

Mintu Turakhia M.D. M.A.S. is a cardiac electrophysiologist, outcomes researcher, and clinical trialist. In his clinical role as Chief of EP at the VA, Dr. Turakhia performs invasive procedures such as catheter ablation and device implantation to treat heart rhythm disorders. Dr. Turakhia has an active, highly-funded multidisciplinary program in Atrial Fibrillation, where uses large datasets to examine quality, outcomes, and risk prediction for heart rhythm disorders. As the Executive Director of Stanford’s new Center for Digital Health, he is the principal investigator of several multi-center trials to test digital health tools and wearable devices to screen and manage heart rhythm disorders. Dr. Turakhia is a Fellow of the American Heart Association, American College of Cardiology, and Heart Rhythm Society.

Glenn Van Langenhove, MD

Fulgur Medical
Merelbeke
Belgium

Invited Faculty: Glenn Van Langenhove, MD

Stephan von Bardeleben, MD

Heart Center Mainz
Mainz
Germany

Invited Faculty: Stephan von Bardeleben, MD

Dee Dee Wang, MD

Henry Ford Heart and Vascular Institute
Detroit
USA

Invited Faculty: Dee Dee Wang, MD
More

Dee Dee Wang, MD

Henry Ford Heart and Vascular Institute
Detroit, USA

Invited Faculty: Dee Dee Wang, MD
Dee Dee Wang, M.D., FACC, FASE, FSCCT  specializes in Interventional Imaging in Structural Heart Interventions including Transcatheter mitral valve replacement therapies, tricuspid interventions, mitral e-clip, complex TAVRs/adult-congenital cases, LAA interventions, and ASD/PFO closures.
Dr. Wang’s research interests are focused on advancing patient safety and procedural outcomes utilizing 3D+4D imaging for high-risk Structural Heart Interventions. She is currently the Director of Structural Heart Imaging at Henry Ford Hospital’s Center for Structural Heart Disease, Medical Director of 3D Printing at Henry Ford Innovations Institute, and Director of the  CT CoreLab at Henry Ford Hospital’s Center for Structural Heart Disease.

Wei Wang, MD

Fuwai Hospital
Beijing
China

Invited Faculty: Wei Wang, MD

David Wilber, MD

Loyola University Medical Center
Maywood
USA

Invited Faculty: David Wilber, MD
More

David Wilber, MD

Loyola University Medical Center
Maywood, USA

Invited Faculty: David Wilber, MD
David Wilber, MD, FAHA, FACC, George M. Eisenberg Professor of Medicine and director, Electrophysiology Section and Cardiovascular Institute, Loyola University Medical Center. Dr. Wilber received his medical degree from Northwestern University Medical School and completed his residency in Internal Medicine at Northwestern Memorial Hospital. He completed his fellowship in cardiovascular disease at the University of Michigan Hospitals and a fellowship in Clinical Cardiac Electrophysiology at Massachusetts General Hospital. His career clinical and research interests have focused on risk stratification and prevention of sudden cardiac death, and mechanisms and ablation of ventricular tachycardia and atrial fibrillation. He has been named annually to Top Doctors in Chicago and the US since 2001. Dr. Wilber is the author or coauthor of more than 500 original articles, book chapters and abstracts, and has served on the steering committee for several multicenter clinical trials.

Jim Wudel, MD

CHI Health Nebraska Heart
Lincoln
USA

Invited Faculty: Jim Wudel, MD
More

Jim Wudel, MD

CHI Health Nebraska Heart
Lincoln, USA

Invited Faculty: Jim Wudel, MD
Dr Jim Wudel is a cardiac and thoracic surgeon with over twenty years experience in the area of structural heart disease(SHD).  After completing his training at UCSF and the Cleveland Clinic Foundation, he joined the Nebraska Heart Institute in Lincoln, NE.  He quickly became part of the heart failure and cardiac transplant program and was a co-investigatior in the landmark REMATCH LVAD trial for end stage heart failure. He has extensive experience in the surgical therapy for functional mitral regurgitation and has been a principal investigator for the ACORN, Myocor, and COAPT trials. His practice has transitioned  to a focus on transcatheter therapies for SHD including TAVR, TMVR and MitraClip.  He is active in the investigational evaluation of the Ancora Heart percutaneous ventriculoplasty system for functional mitral regurgitation and heart failure.

Yongquan Xie, MD

Fuwai Hospital, National Center for Cardiovascular Disease
Beijing
China

Invited Faculty: Yongquan Xie, MD
More

Yongquan Xie, MD

Fuwai Hospital, National Center for Cardiovascular Disease
Beijing, China

Invited Faculty: Yongquan Xie, MD
Dr. Yongquan Xie, M.D. is a surgeon who works in Cardiovascular Surgery Dept of Fuwai Hospital, the National Center For Cardiovascular Disease of China. He got his doctor degree in Peking United College in 2000. From May 2008 to May 2009, he has been a visiting doctor in Cardiothoracic Surgery Department of University of Southern California and worked with Dr. Von Starnes. He has been trained for more than 22 years of cardiac surgery and catheter intervention. He is interested in Cardiac Surgery, surgical and catheter therapy of structural cardiac disease. He has finished more than 1000 cases of cardiac surgery and catheter intervention therapy. Dr. Xie specialized in CABG, valvular repair and replacement, surgical repair or transthoracic and transcatheter occlusion of ASD, VSD and PDA.
CSI   CSI
Contact Data Privacy Imprint Home CSI 2017